Drosophila metabolize 1,4-butanediol into gamma-hydroxybutyric acid in vivo

Eur J Pharmacol. 2003 Jul 25;473(2-3):149-52. doi: 10.1016/s0014-2999(03)01993-9.

Abstract

A solvent, 1,4-butanediol, is also abused as a recreational drug. In mammals, 1,4-butanediol is metabolized into gamma-hydroxybutyric acid (GHB), which stimulates metabotropic gamma-aminobutyric acid (GABA) GABAB and putative GHB receptors. Here we show that in vivo injection of 1,4-butanediol into adult Drosophila leads to GHB synthesis (GHB was detectable 5 min after 1,4-butanediol injection and increased dramatically 1-2 h later). This synthesis of GHB was accompanied by an impairment of locomotor activity that was mimicked by a direct injection of GHB into flies. We propose Drosophila as a model to study the molecular actions of 1,4-butanediol and GHB.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Butylene Glycols / metabolism*
  • Drosophila melanogaster / metabolism*
  • Gas Chromatography-Mass Spectrometry
  • Male
  • Sodium Oxybate / metabolism*
  • Time Factors

Substances

  • Butylene Glycols
  • Sodium Oxybate
  • 1,4-butanediol